Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Klaus Gottlieb
Lovastatin Lactone May Improve Irritable Bowel Syndrome With Constipation (IBS-C) by Inhibiting Enzymes in the Archaeal Methanogenesis Pathway
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
The FDA Adaptive Trial Design Guidance in a Nutshell - A Review in Q&A Format for Decision Makers
Related publications
The Role of Inflammation in Irritable Bowel Syndrome (IBS)
Journal of Inflammation Research
Allergy
Immunology
Abdominal Bloating Is the Most Bothersome Symptom in Irritable Bowel Syndrome With Constipation (IBS-C): A Large Population-Based Internet Survey in Japan
BioPsychoSocial Medicine
Psychiatry
Social Psychology
Mental Health
Psychology
Biological Psychiatry
PWE-026 Effects of 26 Weeks of Linaclotide Treatment on Adequate Relief and IBS Severity in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): Abstract PWE-026 Table
Gut
Gastroenterology
PTU-152 Significant Improvements in Abdominal Pain and Bowel Symptoms in a Phase 3 Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): A European Perspective
Gut
Gastroenterology
Pgi46 - Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation (Dibss-C)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Linaclotide: A New Option for the Treatment of Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation in Adults
Clinical Medicine Insights: Gastroenterology
Gastroenterology
Irritable Bowel Syndrome Subtype Screening Characteristics: Constipation Subtype Patient Profiles Explored
Gastroenterology Insights
Hepatology
Gastroenterology
A Prospective Unicentric Study of the Prevalence of Celiac Disease in Patients With Irritable Bowel Syndrome (IBS)
Annals of International medical and Dental Research
Origin of Increased Fecal Serine Protease in Patients With Irritable Bowel Syndrome and Diarrhoea (IBS-D)
Gut
Gastroenterology
